InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
-0.02%
)
US TECH 100
17,724.00
(
0.00%
)
Dow Jones
39,431.51
(
-0.21%
)
Brent Oil
82.98
(
-0.28%
)
Bitcoin
61,859.21
(
-1.66%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Whosetosay

Send PM Follow Ignore
Followers 26
Posts 4429
Boards Moderated 0
Alias Born 06/08/2010

Whosetosay

Re: None

Wednesday, 09/28/2016 6:28:48 PM

Wednesday, September 28, 2016 6:28:48 PM

Post# of 80490
So today, presciently, Ariad lost at more than their regular $1M/day rate with more equity payouts. Importantly, there was some tax selling of shares to pay tax on the award.

In the past br has pointed this out and commented on it as the seller not having faith in the future of the company, i.e. that the stock would rise. Some said it was a a 10b-5 requirement.

Apparently it is not a a 10b-5 requirement. br appears to have a point. Other biotech execs don't sell for tax (e.g. EXEL) and neither did Bollag. Why do most Ariad execs sell?

The BoD overpaid themselves and the CEO, they breached their fiduciary responsibilities, they doctored their records and coerced and bought off their accuser...I want THE TRUTH!!!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up